A #COVIDBooster Dose Developed by #China's Sinopharm Has Shown to Generate Weaker Immune ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'A #COVIDBooster dose developed by #China's Sinopharm has shown to generate weaker immune responses against the new highly transmissible #OmicronVariant, known to evade vaccine efficacy.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)